Prusogliptin , developed by CSPC Ouyi Pharmaceutical, is a novel oral dipeptidyl peptidase-4 (DPP-4) inhibitor that was approved by National Medical Products Administration (NMPA) on January 8, 2025
But not all telehealth companies are adequately evaluating patients before writing prescriptions, said Marc-Andre Cornier, an endocrinologist at the Medical University of South Carolina and the immediate past president of The Obesity Society
This is due to the obesity and diabetes management centers
Common Mistakes to Avoid When Taking L-Carnitine Even those who understand how to take L-Carnitine can make common mistakes that hinder its effectiveness
This support can make your weight loss journey more affordable and less stressful
Semaglutide and Liraglutide are longer-acting, which means they provide steady appetite regulation and blood sugar support